1. "2020"
Formats
  1. Journal Article (2337)
  2. Meeting Abstract (1901)
  3. Review (493)
  4. Editorial (342)
  5. Correspondence (121)
  6. Guidelines (114)
  7. Book Section (99)
  8. Research Letter (95)
  9. Miscellaneous (61)
  10. Conference Paper (33)
  11. Book Whole (2)
Groups
  1. Department of Medicine (2560)
  2. Solid Tumor Oncology Division (1535)
  3. GSK Faculty (1257)
  4. Sloan Kettering Institute Postdocs (1240)
  5. Hematologic Malignancies, Division of (936)
  6. Survivorship Research (930)

More Groups

People
  1. Jorge Reis-Filho (93)
  2. Miguel-Angel Perales (93)
  3. Sergio Giralt (91)
  4. Alexander Drilon (81)
  5. Britta Weigelt (76)
  6. Nadeem Abu-Rustum (71)

More People

Years
  1. 2020 (5598)
Publications
  1. Journal of Clinical Oncology (500)
  2. Blood (212)
  3. Cancer Research (185)
  4. Annals of Oncology (152)
  5. International Journal of Radiation Oncology, Biology, Physics (129)
  6. Laboratory Investigation (116)

More Publications

Publishers
  1. Elsevier Inc. (714)
  2. American Society of Clinical Oncology (548)
  3. Nature Publishing Group (385)
  4. American Association for Cancer Research (357)
  5. Oxford University Press (356)
  6. Springer (342)

More Publishers

Results (5598)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Erythroid specificity and safety of globin-encoding lentiviral vectors
    Meeting Abstract

    Cabriolu, A.; Odak, A.; Kogel, F.; Sadelain, M.
    Blood (2020)

    Fulltext@MSK | Save
  • A single-arm, open-label phase 1 study of itacitinib (ITA) with calcineurin inhibitor (CNI)-based interventions for prophylaxis of graft-versus-host disease (GVHD; GRAVITAS-119)
    Meeting Abstract

    Choe, H.; Shah, N. N.; Chevallier, P.; Rubio, M. T.; Schroeder, M. A.; Hardy, N. M.; Stiff, P. J.; Solano, C.; Yakoub-Agha, I.; Gutman, J. A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Longitudinal molecular profiling in patients with IDH1-mutant newly diagnosed acute myeloid leukemia treated with ivosidenib
    Meeting Abstract

    Choe, S.; Wang, H.; Roboz, G. J.; DiNardo, C. D.; Stein, E. M.; Mims, A. S.; Prince, G. T.; Watts, J. M.; Fan, B.; Nejad, P.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Impact of comorbidities on response outcomes in patients with chronic myeloid leukemia in chronic phase treated with first-line dasatinib versus imatinib: Exploratory post hoc analysis of DASISION
    Meeting Abstract

    Breccia, M.; Mauro, M. J.; Jabbour, E.; Saglio, G.; Jimenez-Velasco, A.; le Coutre, P. D.; DeGutis, I.; Khan, W.; Sy, O.; Swanink, R.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Bosutinib (BOS) versus imatinib for newly diagnosed chronic phase (CP) chronic myeloid leukemia (CML): Final 5-year results from the BFORE trial
    Meeting Abstract

    Brümmendorf, T. H.; Cortes, J. E.; Milojkovic, D.; Gambacorti-Passerini, C.; Clark, R. E.; le Coutre, P. D.; Garcia-Gutiérrez, V.; Chuah, C.; Kota, V.; Lipton, J. H.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Influence of aging processes on the biology and outcome of multiple myeloma
    Meeting Abstract

    Boyle, E. M.; Williams, L.; Blaney, P.; Ashby, C.; Bauer, M. A.; Walker, B. A.; Choi, J.; Caro, J.; Razzo, B.; Arbini, A. A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Mosunetuzumab shows promising efficacy in patients with multiply relapsed follicular lymphoma: Updated clinical experience from a phase I dose-escalation trial
    Meeting Abstract

    Assouline, S. E.; Kim, W. S.; Sehn, L. H.; Schuster, S. J.; Cheah, C. Y.; Nastoupil, L. J.; Shadman, M.; Yoon, S. S.; Matasar, M. J.; Diefenbach, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Comparison of fixed vs ALC-based doses of thymoglobulin® (ATG) in pediatric patients with acute leukemia given αβhaplo-HSCT: Impact on immune reconstitution at day 90
    Meeting Abstract

    Barbarito, G.; Shyr, D. C.; Saini, G.; Oppizzi, L.; Liu, Y. L.; Patil, R.; Boelens, J. J.; Bertaina, A.
    Blood (2020)

    Fulltext@MSK | Save
  • Trial in progress: A phase I trial of BTX-A51 in patients with relapsed or refractory AML or high-risk MDS
    Meeting Abstract

    Ball, B. J.; Stein, A. S.; Borthakur, G.; Murray, C.; Kook, K.; Chan, K. W.; Stein, E. M.
    Blood (2020)

    Fulltext@MSK | Save
  • Clonal hematopoiesis and COVID-19 severity in cancer patients
    Meeting Abstract

    Bolton, K. L.; Foote, M.; Jee, J.; Safonov, A.; Ptashkin, R.; Devlin, S.; Gedvilaite, E.; Gao, T.; Papaemmanuil, E.; Pessin, M. S.; more...
    Blood (2020)

    Fulltext@MSK | Save